A World Without Infectious Disease

Johanna Friedl-Naderer photoJohanna Friedl-Naderer


Mrs. Friedl-Naderer serves as Executive Vice President and Chief Operating Officer. In this role, she is responsible for overseeing the Company’s business development, finance, product development/regulatory and corporate affairs operations. Her leadership of our corporate and portfolio strategy and global operations helps support our mission of ensuring that patients around the world have access to breakthrough medicines.

Throughout her career, Mrs. Friedl-Naderer has assembled and led diverse, multi-disciplinary teams focused on advancing access to transformational medicines for devastating neurological conditions, such as multiple sclerosis, spinal muscular atrophy, amyotrophic lateral sclerosis and Alzheimer’s disease. 

Prior to joining Vir in March of 2022, Mrs. Friedl-Naderer was President of Europe, Canada & Partner Markets at Biogen, where she was also part of the company’s Global Leadership Team. During her more than 25 years of experience in the biotech and pharmaceutical industry, including more than 20 years at Biogen, she served in leadership positions across a wide range of functions including sales and marketing, national and international general management and alliance management, both for primary and specialty care.

Mrs. Friedl-Naderer has also served on several boards, including for the European Federation of Pharmaceutical Industries & Associations (EFPIA), the Swiss-American Chamber of Commerce, Interpharma and the council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).